肥胖是癌症的系统级驱动因素:机制和营养重编程
Camelia Munteanu1, Danny N Dhanasekaran2,3,4
1Biology Section, Faculty of Agriculture, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania.
概括
肥胖通过改变荷尔蒙,新陈代谢和炎症来驱动癌症. 精准营养为癌症预防和治疗重新编程这种致癌生态系统提供了一种新的方法.
科学领域:
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
- 癌症生物学 癌症生物学
背景情况:
- 肥胖是一个全球性的健康危机,与癌症发病率和死亡率的增加有关.
- 肥胖和癌症之间的机制联系是复杂的,涉及系统性变化.
- 肥胖是一种瘤性压力因素,影响荷尔蒙信号,免疫代谢和表观遗传学.
研究的目的:
- 审查肥胖与癌症相关的生理,细胞和分子机制.
- 探索饮食在调节肥胖相关癌症发生中的作用.
- 为突出癌症预防和治疗的精密营养瘤学的新兴策略.
主要方法:
- 文献综述综合了关于肥胖和癌症的当前知识.
- 分析包括慢性炎症,代谢重编程和微生物组失调症在内的机制.
- 通过表观遗传重编程检查饮食模式及其对癌症生物学的影响.
主要成果:
- 肥胖通过慢性炎症,代谢转变和瘤微环境变化促进癌症发生.
- 饮食模式可以通过表观遗传修改重新编程癌症生物学.
- 精准营养,利用营养基因组学和代谢学,提供个性化的癌症预防和代谢向.
结论:
- 肥胖是一种可修改的致癌生态系统,而不仅仅是风险因素.
- 个性化精确的饮食干预可以重新编程与肥胖相关的癌症生物学.
- 建议在癌症管理方面转向将肥胖视为可针对性生态系统的模式转变.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Psychoneuroimmunology: Diabetes and Cancer
404
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
404
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
218
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
218
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
153
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
153


